Evidence map›Paper›PMID 35011572›Full record

ReviewCells2021

Kei Hori, Kazumi Shimaoka, Mikio Hoshino

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Molecular basis of autism spectrum disorders.Molecular biology reports · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kei HoriDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan.ORCID 0000-0002-2762-6877
Kazumi ShimaokaDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan.
Mikio HoshinoDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502, Japan.
National Center of Neurology and Psychiatry · JP

Funding

Intramural Research Grant of NCNP Grants 30-9, 1-4Japan Agency for Medical Research and Development 19dm0107085h0004, JP21wm0425005Japan Health Research Promotion Bureau (JH) under Research Fund 2020-B-07Japan Society for the Promotion of Science 16H06528, 18H02538, 16K07021Princess Takamatsu Cancer Research Fund Not applicableTakeda Foundation Not applicableThe Mother and Child Health Foundation Not applicableUehara Foundation Not applicable
6 · The paper itself

Abstract

Neurodevelopmental disorders (NDDs), including autism spectrum disorders (ASD) and intellectual disability (ID), are a large group of neuropsychiatric illnesses that occur during early brain development, resulting in a broad spectrum of syndromes affecting cognition, sociability, and sensory and motor functions. Despite progress in the discovery of various genetic risk factors thanks to the development of novel genomics technologies, the precise pathological mechanisms underlying the onset of NDDs remain elusive owing to the profound genetic and phenotypic heterogeneity of these conditions. Autism susceptibility candidate 2 (

Indexed as

AnimalsCytoskeletonGene Expression RegulationGenetic Association StudiesHumansNeurodevelopmental DisordersNeurogenesisTranscription FactorsTranscription Factorsautism spectrum disorders (ASD)autism susceptibility candidate 2 (AUTS2)cerebellumcytoskeletonepigenetic modulationneuritogenesisneurogenesisneuronal migrationsynapse

Identifiers

PMID35011572
PMCPMC8750789
OpenAlexW4200395543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.